Iakovos Kritikos

Mr. Iakovos Kritikos

Bioengineering, Imperial College London, London, City of London, UK
+3
orcid
Biomedical Engineer

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
GAGeorgios Ar. Alevizopoulos
Georgios Ar. Alevizopoulos
Dimitris Dionissios KoutsourisDimitris Dionissios Koutsouris
Dimitris Dionissios Koutsouris
Virtual reality (VR) constitutes an alternative, effective, and increasingly utilized treatment option for people suffering from psychiatric and neurological illnesses. However, the currently available VR simulations provide a predetermined simulative framework that does not take into account the unique personality traits of each individual; this could result in inaccurate, extreme, or unpredictable responses driven by patients who may be overly exposed and in an abrupt manner to the predetermined stimuli, or result in indifferent, almost non-existing, reactions when the stimuli do not affect the patients adequately and thus stronger stimuli are recommended. In this study, we present a VR system that can recognize the individual differences and readjust the VR scenarios during the simulation according to the treatment aims. To investigate and present this dynamically adaptive VR system we employ an Anxiety Disorder condition as a case study, namely arachnophobia. This system consists of distinct anxiety states, aiming to dynamically modify the VR environment in such a way that it can keep the individual within a controlled, and appropriate for the therapy needs, anxiety state, which will be called “desired states” for the study. This happens by adjusting the VR stimulus, in real-time, according to the electrophysiological responses of each individual. These electrophysiological responses are collected by an external electrodermal activity biosensor that serves as a tracker of physiological changes. Thirty-six diagnosed arachnophobic individuals participated in a one-session trial. Participants were divided into two groups, the Experimental Group which was exposed to the proposed real-time adaptive virtual simulation, and the Control Group which was exposed to a pre-recorded static virtual simulation as proposed in the literature. These results demonstrate the proposed system’s ability to continuously construct an updated and adapted virtual environment that keeps the users within the appropriately chosen state (higher or lower intensity) for approximately twice the time compared to the pre-recorded static virtual simulation. Thus, such a system can increase the efficiency of VR stimulations for the treatment of central nervous system dysfunctions, as it provides numerically more controlled sessions without unexpected variations.

1 March 2019
Verified
Conference Paper
Closed access
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
GTGiannis Tzannetos
Giannis Tzannetos
CZChara Zoitaki
Chara Zoitaki
SPStavroula Poulopoulou
Stavroula Poulopoulou
Dimitris Dionissios KoutsourisDimitris Dionissios Koutsouris
Dimitris Dionissios Koutsouris
JKJacob Kritikos
Jacob Kritikos
Nowadays, Virtual Reality (VR) is bringing great benefits to Anxiety Disorder treatments, as well as to other brain cognitive dysfunctions. The advantage of VR is that it can provoke stimuli to the same degree as real-life situations. However, measurement methods of physiological changes caused by the aforementioned stimuli, which apply to VR Anxiety Disorder treatments, have not been examined extensively. As a result, clinicians who use biosignal sensors tend to ask their patients to remain motionless during simulations in order to achieve accurate measurements from the sensors. It is clear that this practice limits the level and range of benefits yielded when using VR simulation. As a consequence, the patients' experience is restricted and so is the potential of the sensors' application in the treatment methods. Furthermore, the data gathered from the sensors is handled using conventional analysis affecting the conclusions drawn about the patients' state. This study aims to emphasise the importance of interacting with the stimuli during the VR treatment through the proposal of an Electrodermal Activity (EDA) Sensor System architecture that can be combined with VR simulations while still allowing the patient to move and interact within the Virtual Environment, without compromising the sensor's measurements. Continuous Deconvolution Analysis is used to draw conclusions from the gathered biosensor data.

25 February 2020 in Sensors
Verified
Journal Article
Open access
PDF file
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
CZChara Zoitaki
Chara Zoitaki
GTGiannis Tzannetos
Giannis Tzannetos
AMAnxhelino Mehmeti
Anxhelino Mehmeti
MDMarilina Douloudi
Marilina Douloudi
Dimitris Dionissios KoutsourisDimitris Dionissios Koutsouris
Dimitris Dionissios Koutsouris
Virtual Reality has already been proven as a useful supplementary treatment tool for anxiety disorders. However, no specific technological importance has been given so far on how to apply Virtual Reality with a way that properly stimulates the phobic stimulus and provide the necessary means for lifelike experience. Thanks to technological advancements, there is now a variety of hardware that can help enhance stronger emotions generated by Virtual Reality systems. This study aims to evaluate the feeling of presence during different hardware setups of Virtual Reality Exposure Therapy, and, particularly how the user’s interaction with those setups can affects their sense of presence during the virtual simulation. An acrophobic virtual scenario is used as a case study by 20 phobic individuals and the Witmer–Singer presence questionnaire was used for presence evaluation by the users of the system. Statistical analysis on their answers revealed that the proposed full body Motion Recognition Cameras system generates a better feeling of presence compared to the Hand Controllers system. This is thanks to the Motion Recognition Cameras, which track and allow display of the user’s entire body within the virtual environment. Thus, the users are enabled to interact and confront the anxiety-provoking stimulus as in real world. Further studies are recommended, in which the proposed system could be used in Virtual Reality Exposure Therapy trials with acrophobic patients and other anxiety disorders as well, since the proposed system can provide natural interaction in various simulated environments.

2 July 2025 in Health Economics and Management Review
Verified
Journal Article
Open access
PDF file
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
ASAndreas Sarantopoulos
Andreas Sarantopoulos
ARAnastasios Roumeliotis
Anastasios Roumeliotis
JVJulia Vasiliades
Julia Vasiliades
IMIoannis Matsinas
Ioannis Matsinas
NUNull
Null
The integration of artificial intelligence into drug discovery processes represents a major innovation in pharmaceutical research and development. This study investigates the role of AI investments in enhancing research efficiency, addressing implementation challenges, and shaping stakeholder perspectives. Via a structured explanatory research design, the study applies a quantitative methodology based on survey data collected from researchers, investors, and pharmaceutical executives across the USA and United Kingdom. The questionnaire examined respondents’ experiences with artificial intelligence tools, investment patterns, and perceived research outcomes. Statistical methods such as logistic regression and chi-square tests were employed to analyze correlations between investment strategies and research efficiency. Findings indicate that while artificial intelligence improves productivity – in predictive modeling and data analysis – barriers such as high infrastructure costs, inadequate training, and regulatory uncertainty persist. Notably, 70% of participants plan to increase AI investments within the next five years, and 80% regard artificial intelligence as essential or very important to the future of drug discovery. However, successful implementation appears to correlate with firm size and access to technical resources, suggesting disparities in AI readiness across the industry. Recommendations include expanding artificial intelligence training programs, strengthening infrastructure, and fostering closer collaboration between investors and researchers. Ethical considerations, including data privacy and regulatory compliance, are also emphasized. The pilot study provides foundational insights for a full-scale investigation and offers practical guidance for optimizing artificial intelligence integration in pharmaceutical research and development.

11 July 2019
Verified
Book Chapter
Closed access
PDF file
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
SPStavroula Poulopoulou
Stavroula Poulopoulou
CZChara Zoitaki
Chara Zoitaki
MDMarilina Douloudi
Marilina Douloudi
DKDimitris Koutsouris
Dimitris Koutsouris

9 June 2023 in Virtual Worlds
Verified
Journal Article
Open access
PDF file
Iakovos KritikosIakovos Kritikos
Iakovos Kritikos
AMAlexandros Makrypidis
Alexandros Makrypidis
AAAristomenis G. Alevizopoulos
Aristomenis G. Alevizopoulos
GAGeorgios Ar. Alevizopoulos
Georgios Ar. Alevizopoulos
Dimitris Dionissios KoutsourisDimitris Dionissios Koutsouris
Dimitris Dionissios Koutsouris
Brain–Machine Interfaces (BMIs) have made significant progress in recent years; however, there are still several application areas in which improvement is needed, including the accurate prediction of body movement during Virtual Reality (VR) simulations. To achieve a high level of immersion in VR sessions, it is important to have bidirectional interaction, which is typically achieved through the use of movement-tracking devices, such as controllers and body sensors. However, it may be possible to eliminate the need for these external tracking devices by directly acquiring movement information from the motor cortex via electroencephalography (EEG) recordings. This could potentially lead to more seamless and immersive VR experiences. There have been numerous studies that have investigated EEG recordings during movement. While the majority of these studies have focused on movement prediction based on brain signals, a smaller number of them have focused on how to utilize them during VR simulations. This suggests that there is still a need for further research in this area in order to fully understand the potential for using EEG to predict movement in VR simulations. We propose two neural network decoders designed to predict pre-arm-movement and during-arm-movement behavior based on brain activity recorded during the execution of VR simulation tasks in this research. For both decoders, we employ a Long Short-Term Memory model. The study’s findings are highly encouraging, lending credence to the premise that this technology has the ability to replace external tracking devices.